Enhancing chemotherapy sensitivity by targeting PcG via the ATM/p53 pathway.
about
Histone methylation in DNA repair and clinical practice: new findings during the past 5-years.Long noncoding RNA PVT1 modulates hepatocellular carcinoma cell proliferation and apoptosis by recruiting EZH2.MiR-1281, a p53-responsive microRNA, impairs the survival of human osteosarcoma cells upon ER stress via targeting USP39
P2860
Enhancing chemotherapy sensitivity by targeting PcG via the ATM/p53 pathway.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Enhancing chemotherapy sensitivity by targeting PcG via the ATM/p53 pathway.
@en
Enhancing chemotherapy sensitivity by targeting PcG via the ATM/p53 pathway.
@nl
type
label
Enhancing chemotherapy sensitivity by targeting PcG via the ATM/p53 pathway.
@en
Enhancing chemotherapy sensitivity by targeting PcG via the ATM/p53 pathway.
@nl
prefLabel
Enhancing chemotherapy sensitivity by targeting PcG via the ATM/p53 pathway.
@en
Enhancing chemotherapy sensitivity by targeting PcG via the ATM/p53 pathway.
@nl
P2093
P2860
P1476
Enhancing chemotherapy sensitivity by targeting PcG via the ATM/p53 pathway.
@en
P2093
Chang-Bao Pan
Guang-Hui Jin
Kang-Li Li
Li-Xiang Xue
Ling-Yu Zhu
Shu-Bin Gao
Shu-Hua Wei
P2860
P304
P577
2017-09-01T00:00:00Z